Cue Biopharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Cue Biopharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 341% to $5,490,000. The net income raised on -$50,733,000 and profit margin reached -924%. Total operating expenses were $19,542,000.

Profit Margin

Cue Biopharma, Inc. (NASDAQ:CUE): Profit margin
2015 0 -1.92M
2016 0 -7.65M
2017 0 -23.23M
2018 1.14M -38.98M -3411.53%
2019 3.45M -36.69M -1061.25%
2020 3.15M -44.78M -1419.79%
2021 14.94M -44.16M -295.56%
2022 1.24M -52.79M -4239.87%
2023 5.49M -50.73M -924.1%

CUE Income Statement (2015 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
5.49M1.24M14.94M3.15M3.45M1.14M000
Cost of revenue
38.09M1.80M-1.77M33.54M27.48M0419.56K044.81K
Gross profit
-32.60M-560.82K16.71M-30.39M-24.02M1.14M-419.56K0-44.81K
Operating exp.
Research and development
40.80M38.57M41.34M33.54M27.48M28.54M18.90M5.68M1.50M
Selling and marketing
000000000
Total operating expenses
19.54M54.74M58.65M48.19M40.22M39.83M23.23M7.65M1.92M
Operating income
-52.14M-53.22M-43.71M-45.04M-36.76M-38.69M-23.23M-7.65M-1.92M
Other income (expenses), net
1.41M214.42K45.89K463.91K483K165.33K35520
Income before tax
-50.73M-53.01M-43.66M-44.57M-36.28M-38.15M-23.23M-7.65M-1.92M
Income tax expense
0-214.42K495K206.25K412K825K000
Net income
-50.73M-52.79M-44.16M-44.78M-36.69M-38.98M-23.23M-7.65M-1.92M
Earnings per share
Basic EPS
-1.11-1.48-1.41-1.56-1.66-1.94-1.13-0.37-0.09
Diluted EPS
-1.11-1.48-1.41-1.56-1.66-1.94-1.13-0.37-0.09
Data sourceData sourceData sourceData sourceData sourceData source